Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Lupin Limited ( (IN:LUPIN) ) is now available.
Lupin Limited has released its Q3 FY25 Investor Presentation, complying with regulatory requirements. This presentation is intended to inform stakeholders about the company’s financial performance and strategic initiatives, potentially impacting its market positioning and investor relations positively.
More about Lupin Limited
Lupin Limited operates in the pharmaceutical industry, providing a range of healthcare products. The company is known for manufacturing generic and branded formulations, biotechnology products, and active pharmaceutical ingredients (APIs), with a focus on catering to both domestic and international markets.
YTD Price Performance: -8.25%
Average Trading Volume: 19,249
Current Market Cap: 1004.1B INR
For a thorough assessment of LUPIN stock, go to TipRanks’ Stock Analysis page.